Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2279
  • 2280
  • 2281
  • …
  • ›
  • »

2025/11/14 09:03

Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK

2025/11/14 09:03

PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.

2025/11/14 09:03

Viasat Confirms Successful Launch of ViaSat-3 F2

2025/11/14 09:00

FLR Investors Have Opportunity to Lead Fluor Corporation Securities Fraud Lawsuit with the Schall Law Firm

2025/11/14 09:00

Wolters Kluwer To Acquire Libra Technology For Up To EUR 90 Mln

2025/11/14 09:00

Dai Nippon Printing Co., Ltd. Profit Falls In H1

2025/11/14 09:00

Nippon Paint Holdings 9-month Profit, Revenue Rise

2025/11/14 09:00

Smoltek Semi Optimizes PECVD System as CNF-MIM Prototype Production Continues

2025/11/14 09:00

Q1 INTERIM REPORT JULY – SEPT 2025

2025/11/14 09:00

Billerud′s long-term Science Based Targets approved – net-zero by 2050

2025/11/14 09:00

Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine

2025/11/14 09:00

Silver Crown Royalties Reports Third Quarter Financial Results

  • «
  • ‹
  • …
  • 2279
  • 2280
  • 2281
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies